$NVGN forming a flag (consolidation) $2.37

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$NVGN forming a flag (consolidation) $2.37


Website

Shares Outstanding: 6.74M
Float: 5.27M

% Held by Insiders: 4.79%
% Held by Institutions: 0.60%
Shares Short (as of Nov 28, 2014): 104.43K
Short Ratio (as of Nov 28, 2014): 2.80
Short % of Float (as of Nov 28, 2014): N/A
Shares Short (prior month): 96.55K




10/31/14 20-F (Australia)
2014 Annual Report - Full Version >>PDF.

Recent Trades
599675067_stockwatch.jpg

Headlines

Friday, December 19, 2014
Novogen Raises An Additional A$1.75m in Private Placement to US Institutions for Aggregate Private Placement of A$5.85mPR Newswire (Fri, Dec 19)

Wednesday, December 17, 2014
Novogen Raises A$4.1m In Private Placement to US InstitutionsPR Newswire (Wed, Dec 17)

Tuesday, December 16, 2014
Novogen Announces Breakthrough Discovery in the Treatment of MelanomaPR Newswire (Tue, Dec 16)
Novogen Shares Skyrocket 120% Following Drug NewsBenzinga (Tue, Dec 16)

Monday, December 15, 2014
Novogen Provides Update On Progress Of Cantrixil Into The ClinicPR Newswire (Mon, Dec 15)

Monday, September 29, 2014
Graham Kelly PhD, CEO & Chairman attended the Rodman & Renshaw 16th Annual Global Investment ConferenceGlobeNewswire (Mon, Sep 29)
ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain CancerPR Newswire (Mon, Sep 29)

Wednesday, September 3, 2014
Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare ConferencePR Newswire (Wed, Sep 3)

Wednesday, August 13, 2014
Novogen Announces Results of General Meeting of ShareholdersPR Newswire (Wed, Aug 13)

Tuesday, August 12, 2014
Novogen Receives Funding Support To Commence Studies In Muscular DystrophyPR Newswire (Tue, Aug 12)

Friday, July 25, 2014
Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™PR Newswire (Fri, Jul 25)

Tuesday, June 17, 2014
Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant Ovarian Cancer Stem CellsPR Newswire (Tue, Jun 17)

Thursday, June 5, 2014
5 Reasons Why We Believe Novogen Is Poised For Successat Seeking Alpha (Thu, Jun 5)

Tuesday, May 27, 2014
Novogen rises 14.7%at theflyonthewall.com (Tue, May 27)
Novogen Identifies Highly Active Drug Candidates Against Prostate CancerPR Newswire (Tue, May 27)

Sunday, May 4, 2014
Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for Childhood CancersPR Newswire (Sun, May 4)

Friday, May 2, 2014
Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative DiseasesPR Newswire (Fri, May 2)

Tuesday, March 18, 2014
Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in VivoPR Newswire (Tue, Mar 18)

Wednesday, March 12, 2014
Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New YorkPR Newswire (Wed, Mar 12)

Monday, March 10, 2014
Novogen Selected to Present at Cavendish Global Health Impact ForumPR Newswire (Mon, Mar 10)


Novogen Limited (NVGN) Stock Research Links

NVGN Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TNBC Advocate Campaign Targets Gaps in Patient Clarity

Updated Category News Views 103

Triple-negative is a heavy phrase to hand somebody without a map. Tigerlily Foundation and the Breast Cancer Resource Center are trying to close that gap with a national education campaign scheduled to launch publicly on January 11, 2027. The plan is straightforward on paper: train and mobilize 100 patient advocates across the country to explain triple-negative breast...

Continue Reading
UTI Faces Fresh Scrutiny After Its Earnings Guidance Miss

Updated Category News Views 113

A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 20

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 82

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 16

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 51

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Bill Targets 15% Federal Goal for Women-Owned Firms

Updated Category News Views 56

Federal procurement has a stubborn habit of sounding abstract until you remember that contracts can decide whether a small company hires, invests, or simply keeps the lights on. Senator Adam Schiff introduced the Women's Economic Fairness and Small Business Contracting Act on November 19, 2026, proposing to raise the federal goal for Women-Owned Small Businesses from 5%...

Continue Reading
Green Lumber Recall Raises a Serious Safety Question

Updated Category News Views 46

A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
IT Tech Packaging's Going-Concern Warning Lands Hard

Updated Category News Views 91

A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharvaris Shares Promising Data on Deucrictibant Efficacy

Updated Category News Views 186

Pharvaris Highlights Clinical Progress in HAE Treatment At the recent AAAAI/WAO Joint Congress, Pharvaris presented compelling long-term clinical data supporting the use of deucrictibant, a novel oral treatment for hereditary angioedema (HAE). This data underscores the drug's potential to not only prevent but also effectively address HAE attacks, offering hope to those...

Continue Reading
First Horizon Opens New Banking Center Celebrating Local Pride

Updated Category News Views 349

First Horizon Unveils New Banking Center with Appalachian Spirit First Horizon Bank (NYSE: FHN) proudly celebrated the grand opening of its newly refreshed banking center. The location pays tribute to the vibrant Appalachian State community, showcasing a striking theme that reflects its strong ties with Appalachian State University and its athletics. This celebration...

Continue Reading
Understanding Namodenoson's Role in Liver Cancer and Beyond

Updated Category News Views 243

Innovative Research on Namodenoson’s Impact in Liver Cancer Therapy Namodenoson, developed by Can-Fite BioPharma Ltd., is making waves in the medical community as a promising candidate for liver cancer treatment. Unlike traditional chemotherapy, which often harms healthy cells, Namodenoson is lauded for its protective qualities towards normal body systems. Published...

Continue Reading
Geotab Enhances Public Sector Solutions with Technological Advancements

Updated Category News Views 147

Geotab Enhances Public Sector Solutions with Technological Advancements Geotab Inc., a leader in connected vehicle solutions and asset management, has taken a major step forward in serving the public sector by expanding its cooperative purchasing contracts with Sourcewell and Canoe Procurement Group. This expansion introduces four cutting-edge solutions aimed at enhancing...

Continue Reading
Dun & Bradstreet Earns TRUSTe Certification for Responsible AI

Updated Category News Views 351

Dun & Bradstreet Achieves TRUSTe Responsible AI Certification Dun & Bradstreet (NYSE:DNB), recognized globally as a leading provider of business decisioning data and analytics, has been awarded the TRUSTe Responsible AI Certification. This certification signifies the company’s commitment to ethical and responsible governance in the realm of artificial intelligence (AI)....

Continue Reading